Portal de Periódicos da CAPES

Allen Roses: From 'Street Fighter' to Corporate Insider

1998; American Association for the Advancement of Science; Volume: 280; Issue: 5366 Linguagem: Inglês

10.1126/science.280.5366.1001

1095-9203

Eliot Marshall,

Biotechnology and Related Fields

On 17 June, the British-based pharmaceutical giant Glaxo Wellcome named controversial Duke University neurologist Allen Roses head of its worldwide genetics research efforts, making him a member of an elite group of ex-academics running big industrial genetics programs. Roses now oversees a $50 million genetics budget, part of Glaxo9s $2 billion annual R&D effort. In recent interviews with Science, Roses discussed his goals for genetics research at Glaxo and his battles with skeptics about his Alzheimer9s work--battles that are legendary in the field and that say a great deal about the drive and approach that Roses brings to his new job.